Over the last decade, the application of new technologieslargely immunohistochemistry and molecular genetics to the study of gynecologic tumors has provided new insights into their pathogenesis. Attempts to integrate the results of these investigations into the conventional clinicopathologic features of the tumors have been made. In this review, which does not intend to be comprehensive, several selected topics dealing with the pathogenesis of gynecologic neoplasms are briefly presented.
1. Prat J. Pathology of vulvar intraepithelial lesions and early invasive carcinoma. Hum Pathol22:877-877, 1991
2.
2. Wilkinson EJ, Kneale B, Lynch PJ. Report of the ISSVD Terminology Committee. J Reprod Med31:973-973, 1986
3.
3. Fu YS, Reagan JW, Townsend DE, et al. Nuclear DNA study of vulvar intraepithelial and invasive squamous neoplasms. Obstet Gynecol57:643-643, 1981
4.
4. Wilkinson EJ, Friedrich EG Jr, Fu YS. Multicentric nature of vulvar carcinoma in situ. Obstet Gynecol58:69-69, 1981
5.
5. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973 to 1987)Am J Obstet Gynecol166:1482-1485, 1992
6.
6. Friedrich EG Jr, Wilkinson EJ, Fu YS. Carcinoma in situ of the vulva. A continuing challenge. Am J Obstet Gynecol136:830-830, 1980
7.
7. Wilkinson EJ. Vulvar intraepithelial neoplasia and squamous cell carcinoma with emphasis on new nomenclature. In Damjanov I, Cohen A, Mills SE, et al. (eds): Progress in reproductive and urinary tract pathology, vol 2. Field & Wood, Philadelphia, p. 1-1, 1990
8.
8. Buscema J, Naghashfar Z, Sawada E, et al. The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstet Gynecol71:601-601, 1988
9.
9. Haefner HK, Tate JE, McLachlin CM, Crum CP. VIN: Age, morphological phenotype, papillomavirus DNA and coexisting invasive carcinoma. Hum Pathol26:147-154, 1995
10.
10. Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva: Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol17:133-145, 1993
11.
11. Carlson JA, Ambros R, Malfetano JH, et al. Vutlvar lichen sclerosus shows premalignant changes not apparent by light microscopy. Mod Pathol10:97A-97A (Abstract), 1997
12.
12. Tate JE, Mutter GL, Boynton KA, Crum CP. Monoclonal origin of vulvar intraepithelial neoplasia and some vulvar hyperplasias. Am J Pathol150:315-322, 1997
13.
13. Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: A clinical study of the outcome in 11 3 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol84:741-745, 1994
14.
14. Buscema J, Woodruff JD, Parmley TH, et al. Carcinoma in situ of the vulva. Obstet Gynecol55:225-225, 1980
15.
15. Korn AP, Abercrombie PD, Foster A. VIN in women infected with HIV-1. Gynecol Oncol6 1:384-386, 1996
16.
16. Esquius J, Brisigotti M, Matias-Guiu X, Prat J. Keratin expression in normal vulva, nonneoplastic epithelial disorders, vulvar intraepithelial neoplasia, and invasive squamous cell carcinoma. Int J Gynecol Pathol10:341-341, 1991
17.
17. Crum CP, Braun LA, Shah KV, et al. Vulvar intraepithelial neoplasia: Correlation of nuclear DNA content and the presence of a human papilloma virus (HPV) structural antigen. Cancer49:468-468, 1982
18.
18. McLachin CM, Mutter GL, Crum CP. Multinucleated atypia of the vulva. Am J Surg Pathol18:1233-1239, 1994
19.
19. Wade TR, Kopf AW, Ackerman AB. Bowenoid papulosis of the genitalia. Arch Dermatol115:306-306, 1979
20.
20. Bergeron C, Nayhashfar A, Canaan C, et al. Human papillomavirus type 16 in intraepithelial neoplasia (bowenoid papulosis) and coexistent invasive carcinoma of the vulva. Int J Gynecol Pathol6:1-1, 1987
21.
21. De Villez RL, Stevens CS. Bowenoid papules of the genitalia: A case progressing to Bowen's disease. J Am Acad Dermatol3:149-149, 1980
22.
22. Twiggs L, Okagaki T, Clark B, et al. A clinical, histopathologic, and molecular biologic investigation of vulvar intraepithelial neoplasia. Int J Gynecol Pathol7:48-48, 1988
23.
23. Wilkinson EJ. Superficial invasive carcinoma of the vulva. Clin Obstet Gynecol28:188-188, 1985
24.
24. Wilkinson EJ. Superficially invasive carcinoma of the vulva. In Wilkinson EJ (ed): Contemporary issues in surgical pathology. Pathology of the vulva and vagina. Churchill Livingstone, New York, p. 103-103, 1987
25.
25. Wilkinson EJ, Rico MJ, Pierson KK. Microinvasive carcinoma of the vulva. Int J Gynecol Pathol11:29-29, 1982
26.
26. Sedlis A, Homesley H, Bundy BN, et al. Positive groin lymph node in superficial squamous cell vulvar cancer. Am J Obstet Gynecol156:1159-1159, 1987
27.
27. Kneale BL. Microinvasive cancer of the vulva. Report of the International Society for the Study of Vulvar Disease Task Force. J Reprod Med29:454-454, 1983
28.
28. Dvoretsky PM, Bonfiglio T, Helmkamp F, et al. The pathology of superficially invasive, thin vulvar squamous cell carcinoma. Int J Gynecol Pathol3:331-331, 1984
29.
29. Hoffman JS, Kumar NB, Morley GW. Microinvasive squamous cell carcinoma of the vulva: Search for a definition. Obstet Gynecol61:615-615, 1983
30.
30. Homesley HD, Bundy BN, Sedlis A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol49:279-283, 1993
31.
31. Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: A prospective study of the Gynecologic Oncology Group. Obstet Gynecol79:490-490, 1992
32.
32. Homesley HD. Management of vulvar cancer. Cancer76:2159-2170, 1995
33.
33. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: A review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynecol97:1135-1139, 1990
34.
34. Zaino RJ, Husseinzadeh N, Nahhas W, Mortel R. Epithelial alterations in proximity to invasive squamous carcinoma of vulva. Int J Gynecol Pathol1:173-184, 1982
35.
35. Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva: Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol17:133-145, 1993
36.
36. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: A clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol10: 107-125, 1991
37.
37. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell63:1129-1136, 1990
38.
38. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science248:76-79, 1990
39.
39. Kagie MJ, Kenter GG, Tollenaar RA, Hermans J, Trimbos JB, Fleuren GJ. p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva. Cancer80:1228-1233, 1997
40.
40. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol15:10-17, 1983
41.
41. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol6:93-108, 1982
42.
42. Ambros RA, Ballouk F, Malfetano JIH, Ross JS. Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus. Am J Surg Pathol18:569-575, 1994
43.
43. Carcangiu ML, Tan LK, Chambers JT. Stage IA uterine serous carcinoma. A study of 13 cases. Am J Surg Pathol21:1507-1514, 1997
44.
44. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol26:1260-1267, 1995
45.
45. Lax SF, Kurman RJ. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analysis. Verh Dtsch Ges Pathol81:228-232, 1997
46.
46. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol9:1-19, 1990
47.
47. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol20:277-285, 1996
48.
48. Sreenan JJ, Hart WR. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol19:666-674, 1995
49.
49. Emoto M, Iwasaki H, Kikuchi M, Shirakawa K. Characteristics of cloned cells of mixed mililerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro. Cancer71:3065-3075, 1993
50.
50. Masuda A, Takeda A, Fukami C, Matsuyama M. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary: Carcinomatous cells are changeable to sarcomatous cells. Cancer60:2696-2703, 1987
51.
51. Meis JM, Lawrence WD. The immunohistochemical profile of malignant mixed mullerian tumor. Overlap with endometrial adenocarcinoma. Am J Clin Pathol94: 1-7, 1990
52.
52. Eifel P, Hendrikson M, Ross J, et al. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer50:163-170, 1982
53.
53. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and the ovary: A clinicopathologic study of 34 cases. Hum Pathol16:28-34, 1985
54.
54. Woodruff JD, Solomon D, Sullivant H. Multifocal disease in the upper genital canal. Obstet Gynecol65:695-698, 1985
55.
55. Russell P, Bannatyne PM, Solomon HJ, Stoddard LD, TattLrdall HN. Multifocal tumorigenesis in the upper female genital tract: Implications for staging and management. Int J Gynecol Pathol4:192-210, 1985
56.
56. Young RH, Scully RE. Metastatic tumors of the ovary. In Kurman R (ed): Blaustein's pathology of the female genital tract, 3rd ed.Springer-Verlag, New York, pp. 742-768, 1987
57.
57. Prat J, Matias-Guiu X, Barreto J. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases. Cancer11:2455-2459, 1991
58.
58. Shenson DL, Gallion HH, Powell DE, Pieretti M. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endomnetrium. Cancer4:650-657, 1995
59.
59. Emmert-Buck MR, Chuaqui R, Zhuang Z, Nogales F, Liotta LA, Merino MJ. Molecular analysis of synchronous uterine and ovarian endometrioid tumors. Int J Gynecol Pathol16:143-148, 1997
60.
60. Fujita M, Enomoto T, Wada H, Inoue M, Okidaira Y, Shroyer KR. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol105:350-359, 1996
61.
61. Catasus LI, Machin P, Lerma E, Matias-Guiu X, Prat J. Microsatellite instability in endometrial carcinomas. Clinicopatlhologic correlations. Hum Pathol (in press)
62.
62. Serov SF, Scully RE, Sobin LH. International histological classification of tumors, no. 9. Histological typing of ovarian tumors. Geneva: World Health Organization, pp. 17-18, 1973
63.
63. Bell DA, Rutgers JL, Scully RE. Ovarian epithelial tumors of borderline malignancy. Progress in reproductive and urinary tract pathology, vol. 1. In Damjanov I, Cohen AH, Mills SE, Young RH (eds): Field and Wood, Inc., Philadelphia, pp. 1-29, 1989.
64.
64. Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer58:2052-2065, 1986
65.
65. De Nictolis M, Montironi R, Tommasoni S, Carinelli S, Ojeda B, Matias-Guiu X, Prat J. Serous borderline tumors of the ovary: A clinicopathologic, immunohistochemical and quantitative study of 44 cases. Cancer70:152-160, 1992
66.
66. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer78:278-286, 1996
67.
67. Katzenstein AA, Mazur MT, Morgan TE, Kao M-S. Proliferative serous tumors of the ovary. Histologic features and prognosis. Am J Surg Pathol2:339-355, 1978
68.
68. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive lowgrade carcinoma related to serous borderline tumors. Am J Surg Pathol20:1319-1330, 1996
69.
69. Eichhorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors of solid, micropapillary and cribriform types: A study of 42 cases. Mod Pathol (Abstract)10:99A-99A, 1997
70.
70. Powell DE, Puls L, van Nagell I. Current concepts in epithelial ovarian tumors: Does benign to malignant transformation occur?Hum Pathol23:846-847, 1992
71.
71. Silva EG, Kurman RJ, Russell P, Scully RE. Symposium: Ovarian tumors of borderline malignancy. Int J Gynecol Pathol15:281-302, 1996
72.
72. Tavassoli FA. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion). Mod Pathol1:407-413, 1988
73.
73. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: A report of 21 cases. Hum Pathol21:397-403, 1990
74.
74. Katabuchi H, Tashiro H, Cho KR, Kurman RJ, Elleson LH. Micropapillary serous carcinoma of the ovary: An immunohistochemical and mutational analysis of p53. Int J Gynecol Pathol17:54-60, 1998
75.
75. Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cordstromal tumors. Am J Surg Pathol6:513-522, 1982
76.
76. Tornos C, Silva ES, Ordonez NG, Gershenson DM, Young RH, Scully RE. Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. Am J Surg Pathol19:1343-1353, 1995
77.
77. Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin and CD 99 expression in sex cord-stromal tumors and sex cord resembling endometrioid ovarian carcinomas. Hum Pathol (in press)
78.
78. Gustafson ML, Lee MM, Scully RE, Moncure AC, Hirakawa T, Goodman A, Muntz HG, Donahoe PK, MacLaughlin DT, Fuller AF. Miillerian inhibiting substance as a marker for ovarian sex cord tumor. N EngI J Med326:466-471, 1992
79.
79. Flemming P, Wellmann A, Maschek H, et al. Monoclonal antibodies for inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Am J Surg Pathol19:927-933, 1995
80.
80. Gurusinghe CJ, Healy DL, Jobling T, et al. Inhibin and activin are demonstrable by immuinohistochemistry in ovarian tumor tissue. Gynecol Oncol57:27-32, 1995
81.
81. Rishi M, Howard LN, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol21:583-589, 1997
82.
82. Arora DS, Cooke IF, Ganesan TS, Ramsdale J, Manek S, Charnok FML, Groome NP, Wells M. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumors of the ovary. J Pathol181:413-418, 1997
83.
83. Riopel MA, Perlman EJ, Seidman JD, Kurman RJ, Sherman ME. Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas. Int J Gynecol Pathol17:46-53, 1998
84.
84. Zheng W, Sung CJ, Hanna I, De Petris G, LambertMesserlian G, Steinhoff M, Lauchlan SC. oc and 3 subunits of inhibin/activin and sex cord-stromal differentiation markers. Int J Gynecol Pathol16:263-271, 1997
85.
85. Loo KT, Leung AKF, Chan JKC. Immunostaining of ovarian granulosa cell tumors with MIC2 antibody. Histopathology27:388-390, 1995
86.
86. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritoneii: A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol15:415-429, 1991
87.
87. Praison R, Hart W, Petras R. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol18:591-603, 1994
88.
88. Ronnett BM, Kurman RJ, Zahn CM, Schmookler BM, Jablonski KA, Kass ME, Sugarbaker PH. Pseudomyxoma peritonei in women: A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol26:509-524, 1995
89.
89. Cuatrecasas M, Matias-Guiu X, Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei: A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol20:739-746, 1996
